September 5, 2014 — The number of uninsured is expected to decline by nearly half from 45 million in 2012 to 23 million by 2023 as a result of the coverage expansions associated with the Affordable Care Act (ACA), according to a report from the Centers for Medicare & Medicaid Services (CMS) Office of the Actuary. The report is published in Health Affairs.

September 5, 2014 — CardiacAssist announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new Protek Duo veno?venous cannula. The Protek Duo is intended for use as a single cannula for both venous drainage and reinfusion of blood via an internal jugular vein during extracorporeal life support (ECLS) procedures.

A new analysis of clinical trial participation in the largest ongoing observational study of U.S. heart attack patients has found participants are not representative of the larger patient base, according to a study led by Women’s College Hospital cardiologist Jay Udell. 

AirStrip, a provider of mobile healthcare applications, has raised $25 million in a strategic funding round led by the Gary & Mary West Health Investment Fund, Sequoia Capital and Wellcome Trust that includes some of the most influential leaders in healthcare.


September 4, 2014 — Medtronic announced CE mark for the 23 mm CoreValve Evolut R system for transcatheter aortic valve implantation (TAVI). The novel self-expanding valve and 14 French equivalent delivery system offers new capabilities that advance valve performance and deliverability during the procedure, while providing the option to recapture and reposition the valve during deployment phase if needed.

September 4, 2014 — St. Jude Medical announced a new multicenter clinical trial has found that using the company’s fractional flow reserve (FFR) technology changed the course of treatment for more than one-fifth of patients suffering non-ST segment elevation myocardial infarction (NSTEMI) heart attacks.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now